Skip to main content

Table 4 Change in vaginal volume (%) in the different groups during follow-up (n = 142)

From: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial

  N Mean SD Min Q1 Median Q3 Max
Testosterone
 0-4a 31 −13.7 15.1 −43.1 −18.0 −10.6 0 10.7
 4-8b 29 −21.0 19.1 −60.8 −40.5 −13.2 −7.5 10.7
 8-12c 28 −24.6 18.3 −64.6 −41.8 −21.1 −8.8 10.7
Estrogen
 0-4a 53 −12.5 13.7 −51.4 −21.0 −9.6 0 10.6
 4-8b 46 −22.8 15.4 −57.1 −36.4 −18.4 −9.7 0
 8-12c 41 −26.3 16.1 −67.5 −37.0 −22.5 −13.8 0
Dilator
 0-4a 27 −8.4 14.65 −36.4 −21.4 −8.1 0 21.4
 4-8b 27 −15.1 21.3 −49.7 −30.0 −13.5 0 36.0
 8-12c 27 −23.9 23.8 −72.2 −39.2 −21.4 −5.7 12.0
Lubricant gel
 0-4a 60 −13.6 15.5 −68.5 −18.1 −9.7 0 9.7
 4-8b 48 −18.5 16.4 −57.8 −32.2 −13.4 −6.3 10.7
 8-12c 46 −26.2 18.4 −60.7 −45.1 −22.6 −10.7 10.7
  1. Kruskal-Wallis test for comparison of mean values between the 4 groups
  2. a0.622 b0.407 c0.844